Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study

Heather Greenlee, Marilyn L Kwan, Isaac Joshua Ergas, Karen J Sherman, Sarah E Krathwohl, Christine Bonnell, Marion M Lee, Lawrence H Kushi, Heather Greenlee, Marilyn L Kwan, Isaac Joshua Ergas, Karen J Sherman, Sarah E Krathwohl, Christine Bonnell, Marion M Lee, Lawrence H Kushi

Abstract

Many women use complementary and alternative medicine (CAM) to maintain or improve their health. We describe CAM use among the first 1,000 participants enrolled in the Pathways Study, an ongoing prospective cohort study of women diagnosed with breast cancer (BC). Participants, identified by rapid case ascertainment in Kaiser Permanente Northern California, are women > or = 21 years diagnosed with first invasive BC. Comprehensive baseline data are collected on CAM use through in-person interviews. Study participants include 70.9% non-Hispanic whites, 10.2% Hispanics, 9.0% Asians, 6.5% African-Americans, and 3.4% others. Most women (82.2%) were diagnosed with AJCC stage I/II BC at average (+/-SD) age 59.5 (+/-12.0) years and reported prior use of at least one form of CAM (96.5% of participants). In the 5 years before diagnosis, CAM therapies used at least weekly by >20% of women included green tea, glucosamine, omega-3 fatty acids, prayer and religion. CAM use was high (86.1% of participants) in the period immediately following diagnosis; 47.5% used botanical supplements, 47.2% used other natural products, 28.8% used special diets, 64.2% used mind-body healing, and 26.5% used body/energy/other treatments. In multivariable analyses, frequent use of each CAM modality before and after diagnosis was associated with use of other CAM modalities and other health behaviors (i.e., high fruit/vegetable intake, lower BMI). CAM use before and after BC diagnosis is common in this diverse group of women. Our results emphasize the need for clinicians to discuss CAM use with all BC patients.

References

    1. American Cancer Society. Breast Cancer Facts & Figures 2007-2008. Atlanta, GA: American Cancer Society, Inc.; 2008.
    1. National Centers for Complementary and Alternative Medicine, National Institutes of Health. What is CAM? 2008. Available via
    1. Eschiti VS. Lesson from comparison of CAM use by women with female-specific cancers to others: it's time to focus on interaction risks with CAM therapies. Integr Cancer Ther. 2007;6:313–344.
    1. Kwan ML, Ambrosone CB, Lee MM, et al. The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control. 2008 May 14; Epub ahead of print.
    1. Bair YA, Gold EB, Greendale GA, et al. Ethnic differences in use of complementary and alternative medicine at midlife: longitudinal results from SWAN participants. Am J Public Health. 2002;92:1832–1840.
    1. Lee MM, Lin SS, Wrensch MR, et al. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst. 2000;92:42–47.
    1. Pierce JP, Faerber S, Wright FA, et al. A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study. Control Clin Trials. 2002;23:728–756.
    1. Gammon MD, Neugut AI, Santella RM, et al. The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat. 2002;74:235–254.
    1. Centers for Disease Control and Prevention, National Center for Health Statistics. 1999-2000 National Health and Nutrition Examination Survey. NHANES 1999-2000 Public Data Release File Documentation. 2000. Available via: .
    1. Centers for Disease Control and Prevention, National Center for Health Statistics. 2000-2001 National Health and Nutrition Examination Survey. NHANES 2001-2002 Public Data General Release File Documentation. 2002. Available via: .
    1. Oehrli MD, Quesenberry CP, Leyden W. 2006 Annual Report on Trends, Incidence, and Outcomes. Kaiser Permanente, Northern California Cancer Registry 2006
    1. Barnes PM, Powell-Griner E, McFann K, et al. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004:1–19.
    1. Gansler T, Kaw C, Crammer C, et al. A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society's studies of cancer survivors. Cancer. 2008;113:1048–1057.
    1. Buettner C, Kroenke CH, Phillips RS, et al. Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study. Breast Cancer Res Treat. 2006;100:219–227.
    1. Newman V, Rock CL, Faerber S, et al. Dietary supplement use by women at risk for breast cancer recurrence. The Women's Healthy Eating and Living Study Group. J Am Diet Assoc. 1998;98:285–292.
    1. Lawenda BD, Kelly KM, Ladas EJ, et al. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst. 2008;100:773–783.
    1. Messina M, McCaskill-Stevens W, Lampe JW. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst. 2006;98:1275–1284.

Source: PubMed

3
Suscribir